CULVER CITY, Calif. — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today announced that Arizona Urology, a premier private urology practice with three locations across Phoenix, has adopted its Unfold AI platform. This first implementation in the state supports a key commercial expansion for Unfold AI in the Southwest U.S. and introduces advanced AI-driven prostate cancer mapping to support more precise treatment planning and patient counseling for localized prostate cancer.
One in eight men are diagnosed with prostate cancer in their lifetime. Today, clinicians predominantly rely on standard imaging and biopsy methods that can miss or underestimate clinically significant disease, creating ongoing challenges in determining the correct course of treatment. This diagnostic gap is particularly critical for the state's growing elderly population and patients referred from rural Arizona communities, who rely on regional care networks to access specialized treatment in the Phoenix metro area.
Unfold AI is an FDA-cleared, multimodal AI platform that combines patient-specific data to create a personalized 3D cancer map, revealing the true size and extent of disease and helping to uncover hidden cancer. By delivering a more complete and accurate view of the tumor and disease spread, Unfold AI empowers physicians to make better informed, patient-specific treatment decisions and reduces the risk of over- or under-treatment.